Adaptive Biotechnologies is a company developing next generation sequencing assays that characterize the adaptive immune system, serving as a platform technology to the research community and the biopharmaceutical industry. Its main product, immunoSEQ, uses a proprietary immune profiling assay to analyze T cells and B cells, critical components of the adaptive immune system’s defense against disease. The company develops a pipeline of clinical assays that are specific to cancer diagnosis and prognosis. Adaptive Biotechnologies’ assays are coupled with a cloud-computing infrastructure that simplifies the interpretation of massive quantities of data in a user-friendly interface.
|HQ||Seattle, WA, US||Map|
Gross profit (Q3, 2020)
Gross profit margin (Q3, 2020), %
Net income (Q3, 2020)
EBIT (Q3, 2020)
Market capitalization (8-Feb-2021)
Closing stock price (8-Feb-2021)
Adaptive Biotechnologies revenue breakdown by business segment: 59.2% from Sequencing revenue and 40.8% from Development revenue
Adaptive Biotechnologies has 3.96k Twitter Followers. The number of followers has increased 1.8% month over month and increased 7.7% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Adaptive Biotechnologies founded?
Adaptive Biotechnologies was founded in 2009.
Who are Adaptive Biotechnologies key executives?
Adaptive Biotechnologies's key executives are Chad Cohen, Nancy Hill and Harlan Robins.
How many employees does Adaptive Biotechnologies have?
Adaptive Biotechnologies has 453 employees.
What is Adaptive Biotechnologies revenue?
Latest Adaptive Biotechnologies annual revenue is $85.1 m.
What is Adaptive Biotechnologies revenue per employee?
Latest Adaptive Biotechnologies revenue per employee is $187.8 k.
Who are Adaptive Biotechnologies competitors?
Competitors of Adaptive Biotechnologies include Proteus Digital Health, Juno Therapeutics and Takeda Pharmaceutical.
Where is Adaptive Biotechnologies headquarters?
Adaptive Biotechnologies headquarters is located at 1551 Eastlake Ave E #200, Seattle.
Where are Adaptive Biotechnologies offices?
Adaptive Biotechnologies has offices in Seattle, New York and South San Francisco.
How many offices does Adaptive Biotechnologies have?
Adaptive Biotechnologies has 3 offices.
Receive alerts for 300+ data fields across thousands of companies